Allergen: | rApi g 1.0101 (Apium gravolens allergen 1.0101), celery |
Unit: | 250µg |
Source: | P. pastorsis |
Mol. Wt: | ~16 kD |
Purification: | Purified from Pichia pastoris culture by multi-step chromatography. Purity > 95% by silver stained SDS-PAGE, run under reducting condidtions. |
Concentration: | See product insert. |
Formulation: | Preservative and carrier free in 1X PBS buffer, pH 7.4 |
Storage: | Store at -20ºC. Aviod repeated freeze-thaw cycles. |
Notes: | (1)rApi g 1 has a C-terminal 6xHis-tag (2)Not tested for endotoxin. |
Product Resources: | Recombinant Api g 1 Certificate of Analysis |
Related products: | |
Allergens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. | |
References: | |
Hoffman-Sommergruber K, Ferris R, Pec M, Radauer C, O’Riordain G, Laimer Da Camarara Machado M, et al. Characterization of Api g 1.0201, new member of the Api g 1 family of celery allergens. Int Arch Allergy Immunol 2000;122(2):115-23. | |
Hoffmann-Sommergruber K, Demoly P, Crameri R, Breiteneder H, Ebner C, Laimer Da Camara Machado M, et al. IgE reactivity to Api g 1, a major celery allergen, in Central European population is based on primary sensitization by Bet v 1. J Allergy Clin Immunol 1999;104:478-84. | |
Hoffman-Sommergruber K, Vanek-Krebitz M, Ferris R, O’Riordain G, Susani M, Hirschwehr R, et al. Isolation and cloning of Bet v 1-homologous food allergens from celeriac (Api g 1) and apple (Mal d 1). Adv Exp Med Biol 1996;409:219-24 | |
Breitenender H, Hoffmann-Sommergruber K, O’Riordain G, Sasani M, Ahorn H, Ebner C, et al. Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa free pollen allergens. Eur J Biochem 1995;(15)233:484-9. | |
Indoor Biotechnologies 由三家附属公司组成,INDOOR Biotechnologies Inc.(IBI),位于美国弗吉尼亚州夏洛茨维尔,INDOOR Biotechnologies Limited(IBL)位于英国卡迪夫,INDOOR Biotechnologies India(IBIndia),新设立于班加罗尔。Indoor Biotechnologies 遍布全球,在日本,中国和韩国拥有授权分销商,在全球约50个国家/地区销售。 Indoor Biotechnologies 生产纯化的天然和重组过敏原,用于研究和开发过敏诊断和疫苗。该产品系列目前包括 50 种纯化的过敏原,其制造具有高纯度和生物活性。这包括具有低内毒素含量的 LoTox™ 过敏原,专为过敏和哮喘的免疫学研究而设计。